{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:22:02Z","timestamp":1781616122661,"version":"3.54.5"},"reference-count":15,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Br J Ophthalmol"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1136\/bjophthalmol-2015-307000","type":"journal-article","created":{"date-parts":[[2015,10,10]],"date-time":"2015-10-10T02:34:25Z","timestamp":1444444465000},"page":"843-847","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["EP3\/FP dual receptor agonist ONO-9054 administered morning or evening to patients with open-angle glaucoma or ocular hypertension: results of a randomised crossover study"],"prefix":"10.1136","volume":"100","author":[{"given":"Michael S","family":"Berlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Rowe-Rendleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ike","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas T","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akifumi","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Ouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Quach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline L","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2015,10,9]]},"reference":[{"key":"key-10.1136\/bjophthalmol-2015-307000-1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1527-3466.2006.00001.x","article-title":"Prostanoids in the therapy of glaucoma","volume":"24","author":"Ishida","year":"2006","journal-title":"Cardiovasc Drug Rev"},{"key":"key-10.1136\/bjophthalmol-2015-307000-2","unstructured":"National Institute for Health and Care Excellence (NICE). Glaucoma: Diagnosis and management of chronic open angle glaucoma and ocular hypertension. https:\/\/www.nice.org.uk\/guidance\/cg85 (accessed 31 Mar 2015)."},{"key":"key-10.1136\/bjophthalmol-2015-307000-3","unstructured":"American Optometric Association (AOA). Optometric clinical practice guideline: Care of the patient with open angle glaucoma. 2011. http:\/\/www.aoa.org\/documents\/optometrists\/CPG-9.pdf (accessed 31 Mar 2015)."},{"key":"key-10.1136\/bjophthalmol-2015-307000-4","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1177\/1060028014548569","article-title":"Comparative efficacy and tolerability of topical prostaglandin analogues for primary open-angle glaucoma and ocular hypertension","volume":"48","author":"Lin","year":"2014","journal-title":"Ann Pharmacother"},{"key":"key-10.1136\/bjophthalmol-2015-307000-5","first-page":"741","article-title":"Chemical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension","volume":"4","author":"Lee","year":"2010","journal-title":"Clinical Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307000-6","first-page":"1475","article-title":"Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues","volume":"43","author":"Schl\u00f6tzer-Schrehardt","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307000-7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jop.2008.0089","article-title":"Prostaglandin subtype-selective and non-selective IOP-lowering comparison in monkeys","volume":"25","author":"Gabelt","year":"2009","journal-title":"Ocul Pharmacol Ther"},{"key":"key-10.1136\/bjophthalmol-2015-307000-8","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1167\/iovs.14-16181","article-title":"IOP-lowering effect of ONO-9054 \u2013 a novel dual agonist of prostanoid EP3 and FP receptors \u2013 in monkeys","volume":"56","author":"Yamane","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key-10.1136\/bjophthalmol-2015-307000-9","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1001\/archopht.1963.00960050304004","article-title":"Diurnal variation of intraocular pressure in treated glaucoma","volume":"70","author":"Drance","year":"1963","journal-title":"Arch Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307000-10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000027290","article-title":"Fluctuations of intraocular pressure during the day in open angle glaucoma, normal tension glaucoma and normal subjects","volume":"212","author":"Sacca","year":"1998","journal-title":"Ophthalmologica"},{"key":"key-10.1136\/bjophthalmol-2015-307000-11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0161-6420(90)32543-5","article-title":"Presence and rapid decline of early morning intraocular pressure peaks in glaucoma","volume":"97","author":"Zeimer","year":"1990","journal-title":"Ophthalmology"},{"key":"key-10.1136\/bjophthalmol-2015-307000-12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/ICU.0b013e32832b7578","article-title":"Dry eye in 2008","volume":"20","author":"Abelson","year":"2009","journal-title":"Curr Opin Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307000-13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/ICO.0b013e3181c11e45","article-title":"Diurnal variation of visual function and the signs and symptoms of dry eye","volume":"29","author":"Walker","year":"2010","journal-title":"Cornea"},{"key":"key-10.1136\/bjophthalmol-2015-307000-14","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0002-9394(03)00098-9","article-title":"A comparison of latanoprost, bimatoprost, and travoprost in patients with elevated intraocular pressure: a 12-week, randomized, masked-evaluator multicenter study","volume":"135","author":"Parrish","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.1136\/bjophthalmol-2015-307000-15","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/IJG.0b013e31821dac86","article-title":"Determinants of medication adherence to topical glaucoma therapy","volume":"21","author":"Dreer","year":"2012","journal-title":"J Glaucoma"}],"container-title":["British Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T08:50:48Z","timestamp":1601110248000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjo.bmj.com\/lookup\/doi\/10.1136\/bjophthalmol-2015-307000"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,9]]},"references-count":15,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2016,5,20]]},"published-print":{"date-parts":[[2016,6]]}},"alternative-id":["10.1136\/bjophthalmol-2015-307000"],"URL":"https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307000","relation":{},"ISSN":["0007-1161","1468-2079"],"issn-type":[{"value":"0007-1161","type":"print"},{"value":"1468-2079","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,9]]}}}